Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse NKp46/NCR1 Antibody, R&D Systems™

Rat Monoclonal Antibody
Supplier: R&D Systems MAB22252
This item is not returnable.
View return policy
Description
NKp46/NCR1 Monoclonal specifically detects NKp46/NCR1 in Mouse samples. It is validated for Flow Cytometry, CyTOF-reported.Specifications
NKp46/NCR1 | |
Monoclonal | |
LYOPH | |
Flow Cytometry 0.25 ug/10^6 cells, CyTOF-reported | |
Q8C567 | |
NCR1 | |
Murine myeloma cell line NSO-derived recombinant mouse NKp46-Fc chimera Glu22-Asn255 Accession # Q8C567 | |
100 μg | |
Primary | |
Detects mouse NKp46/NCR1 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) NKp30, rhNKp44, rhNKp46, or rhNKp80 is observed. | |
Mouse | |
Purified |
Flow Cytometry, CyTOF | |
29A1.4 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
CD335, CD335 antigen, hNKp46, Ly94, LY94lymphocyte antigen 94 homolog (activating NK-receptor; NK-p46), Lymphocyte antigen 94 homolog, MAR-1, natural cytotoxicity triggering receptor 1, Natural killer cell p46-related protein, NCR1, NK cell-activating receptor, NKp46, NKP46FLJ99094, NK-p46lymphocyte antigen 94 (mouse) homolog (activating NK-receptor; NK-p46) | |
Rat | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
9437 | |
Sterile PBS to a final concentration of 0.5 mg/mL. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2a |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction